Publication | Open Access

Renal Shielding and Dosimetry for Patients With Severe Systemic Sclerosis Receiving Immunoablation With Total Body Irradiation in the Scleroderma: Cyclophosphamide or Transplantation Trial

Kidney TransplantSclerodermaMedicineKidney TransplantationSystemic SclerodermaImmunologyTransplantation TrialImmunosuppressive TherapyRenal ShieldingTotal Body IrradiationDermatologyImmunotherapyChronic Kidney DiseaseNephrologyGraft Rejection